Algernon Pharmaceuticals Inc. buy Ruckelsbuckel
Start price
08.01.22
/
80%
€0.89
Target price
08.01.23
€5.50
Performance (%)
38.03%
End price
28.01.22
€1.23
Summary
This prediction ended on 28.01.22 with a price of €1.23. With a performance of 38.03% the BUY prediction by Ruckelsbuckel was a big success. Ruckelsbuckel has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Algernon Pharmaceuticals Inc. | 1.124% | 1.124% | -71.519% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to Ruckelsbuckel what are the pros and cons of Algernon Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Valuable balance sheet
Normal challenges to pay loans and raise capital
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Higher EBIT margin than peer group
Fair valuation
Standard Investments for future growth
Very capable Management
Very good company culture
Strong uniques
Differentiated customer and product portfolio
Growths faster than the competition
Cons
Very low/no dividend yield expected
Bad rating
negative Cash Flow expected